As you know, this is not new, we have been following with great interest the news of the Youtube channel Bloomberg Television for quite some time now because we know that its content is particularly appreciated by our community. And that's why we're telling you about it today, this brand new video should interest you.
You're starting to get used to it, each time a new video is released on the Bloomberg Television Youtube channel, we try to offer it to you as soon as possible on our website. We invite you to discover without further delay the video Astellas Pharma CEO Says Confident of Iveric Bio Drug Approval by going on the player right here!
The video has been posted for less than an hour and is currently the talk of the web. Usually the new videos of the Youtube channel Bloomberg Television are much less talked about. Soon in trends? That's all the bad news we wish him, considering the work this channel has been doing for many years now!
You have problems with this content? You have spotted an error in the video that you want to report to the editor? If you want to give feedback to the creator of the video, feel free to contact the author by going to the "About" section of his youtube channel. Or simply try to reach him on his social networks, it's quite convenient sometimes to tweet!
Normally, if you are still reading this article, it means that the video Astellas Pharma CEO Says Confident of Iveric Bio Drug Approval must have pleased you and that we did not make a mistake in encouraging you to watch it. In our platform, you can find other videos of Bloomberg Television, take a look at it occasionally, it's practical and it can allow you to find contents that you had never seen before on the web!
Ladies and gentlemen, we are coming to the end of this article Croblanc, we hope you have enjoyed reading it, at least as much as we have enjoyed writing it!
For your information, you can find below the description of the video Astellas Pharma CEO Says Confident of Iveric Bio Drug Approval published by the Youtube channel Bloomberg Television:
Naoki Okamura, chief executive officer of Japanese drugmaker Astellas Pharma Inc., discusses his company's decision to acquire Iveric Bio Inc., a developer of drugs to treat age-related blindness, for about $5.9 billion. He also talks about Astellas Pharma's growth strategy with Shery Ahn and Haidi Stroud-Watts on "Bloomberg Daybreak: Asia."
Follow Bloomberg for business news & analysis, up-to-the-minute market data, features, profiles and more: http://www.bloomberg.com
Connect with us on...
Twitter: https://twitter.com/business
Facebook: https://www.facebook.com/bloombergbusiness/
Instagram: https://www.instagram.com/quicktake/?hl=en